AU2003222667A1 - 1,3-thiazoles as lxr modulators in the treatment of cardiovascular diseases - Google Patents

1,3-thiazoles as lxr modulators in the treatment of cardiovascular diseases

Info

Publication number
AU2003222667A1
AU2003222667A1 AU2003222667A AU2003222667A AU2003222667A1 AU 2003222667 A1 AU2003222667 A1 AU 2003222667A1 AU 2003222667 A AU2003222667 A AU 2003222667A AU 2003222667 A AU2003222667 A AU 2003222667A AU 2003222667 A1 AU2003222667 A1 AU 2003222667A1
Authority
AU
Australia
Prior art keywords
thiazoles
treatment
cardiovascular diseases
lxr modulators
lxr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003222667A
Inventor
Thomas Arrhenius
Jie-Fei Cheng
Alex M. Nadzan
Mark Wilson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of AU2003222667A1 publication Critical patent/AU2003222667A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
AU2003222667A 2002-04-23 2003-04-21 1,3-thiazoles as lxr modulators in the treatment of cardiovascular diseases Abandoned AU2003222667A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37465102P 2002-04-23 2002-04-23
US60/374,651 2002-04-23
PCT/US2003/012250 WO2003090746A1 (en) 2002-04-23 2003-04-21 1,3-thiazoles as lxr modulators in the treatment of cardiovascular diseases

Publications (1)

Publication Number Publication Date
AU2003222667A1 true AU2003222667A1 (en) 2003-11-10

Family

ID=29270536

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003222667A Abandoned AU2003222667A1 (en) 2002-04-23 2003-04-21 1,3-thiazoles as lxr modulators in the treatment of cardiovascular diseases

Country Status (2)

Country Link
AU (1) AU2003222667A1 (en)
WO (1) WO2003090746A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005092856A1 (en) * 2004-03-26 2005-10-06 F. Hoffmann-La Roche Ag Tetrahydrocarbazoles and derivatives
FR2869904B1 (en) 2004-05-07 2006-07-28 Fournier S A Sa Lab MODULATORS OF LXR RECEIVERS
JP2013542183A (en) 2010-09-07 2013-11-21 エスエヌユー アールアンドディービー ファウンデーション Sesterterpene compounds and uses of these substances
EP3091970B1 (en) 2014-01-10 2020-10-28 Rgenix, Inc. Lxr agonists and uses thereof
JP7025022B2 (en) 2016-01-11 2022-02-24 ザ ロックフェラー ユニバーシティー Methods for the treatment of myeloid-derived inhibitory cell-related disorders
SG11201900745VA (en) * 2016-07-29 2019-02-27 Lupin Ltd Substituted thiazolo-pyridine compounds as malt1 inhibitors
US11214536B2 (en) 2017-11-21 2022-01-04 Inspirna, Inc. Polymorphs and uses thereof
AU2020401286A1 (en) 2019-12-13 2022-06-23 Inspirna, Inc. Metal salts and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60023492T2 (en) * 1999-05-17 2006-07-20 Novo Nordisk A/S GLUCAGON ANTAGONISTS / INVERSE AGONISTS
DE60233650D1 (en) * 2001-02-20 2009-10-22 Chugai Pharmaceutical Co Ltd METHOD FOR THE TREATMENT OF METABOLISM DISEASES WITH MALONYL COA DECARBOXYLASE INHIBITORS
US6924311B2 (en) * 2001-10-17 2005-08-02 X-Ceptor Therapeutics, Inc. Methods for affecting various diseases utilizing LXR compounds

Also Published As

Publication number Publication date
WO2003090746A1 (en) 2003-11-06

Similar Documents

Publication Publication Date Title
AU2003212323A1 (en) Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases
WO2003072035A8 (en) Compositions and methods for the treatment of immune related diseases
HK1098737A1 (en) Process for the preparation of 1,1,1,3,3-pentafluoro-2-chloropropene and 1,1,1,3,3,3-hexafluoro-2-chloropropane
AU2003290415A1 (en) Herbal oro-dental care composition and process for preparing the same
AU2003211453A1 (en) External compositions for the skin
AU2002210385A1 (en) Furazanyl-triazole derivates for the treatment of diseases
AU2003258145A1 (en) Substituted phenylindoles for the treatment of hiv
AU2003212634A1 (en) Compounds useful in the treatment of cancer
AU2003220521A1 (en) Methods of treatment with lxr modulators
AU2003223684A1 (en) Lxr modulators for the treatment of cardiovascular diseases
AU2003276129A1 (en) Compositions and methods for darkening the skin
AU2003903242A0 (en) Process for the treatment of wood
AU2003254146A1 (en) Methods for the treatment of parkinson's disease
AU2003222667A1 (en) 1,3-thiazoles as lxr modulators in the treatment of cardiovascular diseases
EG24959A (en) Indoles useful in the treatment of androgenreceptor related diseases.
AU2002224839A1 (en) Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
AU2003219511A1 (en) Carnitine in the treatment of geriatric depression
WO2005012275A3 (en) Benzo [1, 2, 5] thiadiazole compounds as cck2 modulators
AU2003255843A1 (en) 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain
GB0201025D0 (en) The treatment of degenerative diseases
WO2004105780A3 (en) Compositions comprising gastrin compounds and their use in diabetes
AU2003240174A1 (en) Compositions for the treatment of edematous-firbrosclerotic panniculopathy
AU2002952537A0 (en) The production of fodder
AU2003240169A1 (en) Dermocosmetic treatment by metabolic phospholipids
AU2003249999A1 (en) 1,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumours

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase